I
AVNS

InceptionR’s Avanos Medical AVNS Stock Holding History

InceptionR’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,939
Closed -$277K – 602
2025
Q3 		$277K Buy
+23,939
New +$280K 0.07% 489

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

InceptionR's AVNS Position: Q4 2025 in Review

InceptionR sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 23,939 shares — an estimated $277K sold.

InceptionR first reported a position in AVNS in Q3 2025 and held it in 1 quarter. The position peaked at $277K in Q3 2025. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

  • InceptionR reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
  • InceptionR sold 23,939 Avanos Medical shares in Q4 2025, an estimated $277K.
  • InceptionR first reported a position in Avanos Medical in Q3 2025 and held it in 1 quarter.
  • InceptionR's Avanos Medical position peaked at $277K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on InceptionR's 13F filing for Q4 2025, filed 11 Feb 2026.